104 related articles for article (PubMed ID: 27386594)
1. [Between depression and fibroniyalgia: the fate of the antidepressant].
Drobizhev MY; Fedotova AV; Kikta SV; Antokhin EY
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(4):114-120. PubMed ID: 27386594
[TBL] [Abstract][Full Text] [Related]
2. Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium.
Bernstein CD; Albrecht KL; Marcus DA
Expert Opin Pharmacother; 2013 May; 14(7):905-16. PubMed ID: 23506481
[TBL] [Abstract][Full Text] [Related]
3. Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant.
Keks NA; Hope J; Keogh S; Copolov DL
Australas Psychiatry; 2018 Oct; 26(5):537-540. PubMed ID: 30198305
[TBL] [Abstract][Full Text] [Related]
4. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia.
Vitton O; Gendreau M; Gendreau J; Kranzler J; Rao SG
Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S27-35. PubMed ID: 15378666
[TBL] [Abstract][Full Text] [Related]
5. Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain.
Leo RJ; Brooks VL
Curr Opin Investig Drugs; 2006 Jul; 7(7):637-42. PubMed ID: 16869117
[TBL] [Abstract][Full Text] [Related]
6. LEVOMILNACIPRAN--A SUCCESSOR OF MILNACIPRAN WITH A HIGHER NORADRENERGIC SELECTIVITY.
Zadka Ł; Dziwota E; Olajossy M
Acta Pol Pharm; 2016; 73(2):285-9. PubMed ID: 27180420
[TBL] [Abstract][Full Text] [Related]
7. Segregating the cerebral mechanisms of antidepressants and placebo in fibromyalgia.
Jensen KB; Petzke F; Carville S; Choy E; Fransson P; Gracely RH; Vitton O; Marcus H; Williams SC; Ingvar M; Kosek E
J Pain; 2014 Dec; 15(12):1328-37. PubMed ID: 25283470
[TBL] [Abstract][Full Text] [Related]
8. Milnacipran: beyond a role of antidepressant.
Pae CU; Marks DM; Shah M; Han C; Ham BJ; Patkar AA; Masand PS
Clin Neuropharmacol; 2009; 32(6):355-63. PubMed ID: 19620845
[TBL] [Abstract][Full Text] [Related]
9. Milnacipran for fibromyalgia.
Dempsey J
Issues Emerg Health Technol; 2008 Feb; (114):1-4. PubMed ID: 18354855
[TBL] [Abstract][Full Text] [Related]
10. Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial.
Matthey A; Cedraschi C; Piguet V; Besson M; Chabert J; Daali Y; Courvoisier D; Montagne A; Dayer P; Desmeules JA
Pain Physician; 2013; 16(5):E553-62. PubMed ID: 24077206
[TBL] [Abstract][Full Text] [Related]
11. Influence of painful physical symptoms in the treatment of Japanese patients with melancholic major depressive disorder: A prospective cohort study.
Sekine A; Hozumi S; Shimizu T
Psychiatry Res; 2016 Aug; 242():240-244. PubMed ID: 27294798
[TBL] [Abstract][Full Text] [Related]
12. Is milnacipran effective in treating pain in patients with fibromyalgia?
Simon LS
Nat Clin Pract Rheumatol; 2006 Mar; 2(3):126-7. PubMed ID: 16932669
[No Abstract] [Full Text] [Related]
13. A case of temporo-mandibular disorder with fibromyalgia treated with the antidepressant, milnacipran.
Toyofuku A; Miyako H
Hum Psychopharmacol; 2004 Jul; 19(5):357-8. PubMed ID: 15252831
[No Abstract] [Full Text] [Related]
14. Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.
Arnold LM; Palmer RH; Gendreau RM; Chen W
Psychosomatics; 2012; 53(4):371-9. PubMed ID: 22677218
[TBL] [Abstract][Full Text] [Related]
15. Chronopharmacological Analysis of Antidepressant Activity of a Dual-Action Serotonin Noradrenaline Reuptake Inhibitor (SNRI), Milnacipran, in Rats.
Kawai H; Machida M; Ishibashi T; Kudo N; Kawashima Y; Mitsumoto A
Biol Pharm Bull; 2018; 41(2):213-219. PubMed ID: 29386481
[TBL] [Abstract][Full Text] [Related]
16. A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome.
Uçeyler N; Häuser W; Sommer C
Arthritis Rheum; 2008 Sep; 59(9):1279-98. PubMed ID: 18759260
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Comorbid Depression Taking Concurrent Antidepressant Medication: A Randomized, Placebo-controlled Study.
Arnold LM; Sarzi-Puttini P; Arsenault P; Khan T; Bhadra Brown P; Clair A; Scavone JM; Driscoll J; Landen J; Pauer L
J Rheumatol; 2015 Jul; 42(7):1237-44. PubMed ID: 26034150
[TBL] [Abstract][Full Text] [Related]
18. Milnacipran: in fibromyalgia.
Chwieduk CM; McCormack PL
Drugs; 2010; 70(1):99-108. PubMed ID: 20030428
[TBL] [Abstract][Full Text] [Related]
19. ACS chemical neuroscience molecule spotlight on savella.
Hopkins CR
ACS Chem Neurosci; 2010 May; 1(5):345. PubMed ID: 22778830
[TBL] [Abstract][Full Text] [Related]
20. Fibromyalgia, milnacipran and experimental pain modulation: study protocol for a double blind randomized controlled trial.
Macian N; Pereira B; Shinjo C; Dubray C; Pickering G
Trials; 2015 Apr; 16():134. PubMed ID: 25873248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
